Region:

Eupraxia Pharmaceuticals Inc. Announces $10 Million Convertible Debt Agreement with Silicon Valley Bank and Conversion of $6.0 Million pre-IPO Debt

Client News  |  21. Juni 2021

Now Let's Get Started

 

See how SVB makes next happen now for entrepreneurs like you.

Connect with Us